Monday, August 15, 2011

Nile reduces Q2 loss

Nile Therapeutics Inc. lost $880,530 in the June quarter, down from a loss of $1.5 million a year earlier in the same period.
San Mateo-based Nile (Pink Sheets: NLTX) had $346,000 in revenue in the most recent quarter, compared with no revenue in the second quarter of 2010.

No comments:

Post a Comment